332
Participants
Start Date
November 2, 2021
Primary Completion Date
June 29, 2024
Study Completion Date
July 18, 2024
IUO Acute Leukemia Panel
This Investigational Panel , comprised of 6 reagents , is intended for in vitro diagnostic use for qualitative flow-cytometric immunophenotyping of immature hematopoietic cell populations. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having, B-cell acute lymphoblastic leukemia or acute myeloid leukemia.
New York-Presbyterian Hospital Weill Cornell Medicine, New York
University Of North Carolina, Chapel Hill
University of Salamanca, Salamanca
CorePath Laboratories, San Antonio
Childrens Hospital Los Angeles, Los Angeles
Fleury Group, São Paulo
Motol University Hospital, Childhood Leukemia Investigation, Prague
Cambridge University, Cambridge
Lead Sponsor
Becton, Dickinson and Company
INDUSTRY